Alpha and omega o f microbes. Antibiotics and probiotics: Judicious use is the key;L'abécédaire des microbes. Les antibiotiques et les probiotiques: Un recours judicieux est de mis

Canadian Family Physician

Volumn 50, Issue APR., 2004, Pages 525-531

  Conly, John ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFALEXIN; CEFTRIAXONE; PENICILLIN G; PREBIOTIC AGENT; PROBIOTIC AGENT; SULFONAMIDE; YOGHURT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL INFECTION; BIFIDOBACTERIUM; BITE; BLADDER TUMOR; BRONCHITIS; CANADA; CAT; CLINICAL PRACTICE; CONTINUING EDUCATION; DEMOGRAPHY; DIARRHEA; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DOG BITE; DRUG USE; EDITORIAL; EDUCATION PROGRAM; ENVIRONMENTAL SANITATION; ESCHERICHIA COLI; EXPERIENCE; FOOD ALLERGY; FOOD COMPOSITION; GASTROINTESTINAL INFECTION; GASTROINTESTINAL TUMOR; GENERAL PRACTITIONER; HELICOBACTER PYLORI; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INTESTINE FLORA; LACTOBACILLUS; LISTERIA; MEDLINE; PASTEURELLA; PHYSICIAN ATTITUDE; PRESCRIPTION; PROSPECTIVE STUDY; QUALITY CONTROL; SALMONELLA; TREATMENT OUTCOME; URINARY TRACT INFECTION; UTERINE CERVIX TUMOR; VAGINITIS; DRUG RESISTANCE; NOTE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE; HUMANS; PROBIOTICS;

EID: 2342557137     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. Weinstein L. General considerations. In: Goodman LS, Gilman A, editors. The pharmacological basis of therapeutics. New York, NY: Macmillan; 1970. p. 1154.
2. The Nobel Foundation, Nobel e-museum. Fleming A. Nobel Lecture, December 11, 1945 [webpage]. Stockholm, Sweden: The Nobel Foundation; 1945. Available from: http://www.nobel.se/medicine/laureates/1995/fleming-lectur.html. Accessed 2004 Feb 10.
3. Alvarez-Olmos MI, Oberhelman RA. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis 2001;32(11):1567-76.
4. Macfarlane GT, Cummings JH. Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? BMJ 1999;318:999-1003.
5. Tuohy KM, Probert HM, Smejkal CW, Gibson GR. Using probiotics and prebiotics to improve gut health. Drug Discov Today 2003;8:692-700.
6. Clancy R. Immunobiotics and the probiotic evolution. FEMS Immunol Med Microbiol 2003;38:9-12.
7. Miller M. "Probiotics" a research paper. BMJ 1996;312:55-6.
8. Conly J. Controlling antibiotic resistance by quelling the epidemic of overuse and misuse of antibiotics. Can Fam Physician 1998;44:1769-73 (Eng), 1780-4 (Fr).
9. Report of the ASM task force on antibiotic resistance. Antimicrob Agents Chemother 1995;(Suppl):1-23.
10. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996;275:234-40.
11. Swartz MN. Use of antimicrobial agents and drug resistance. N Engl J Med 1997;337:491-2.
12. Conly J. Antimicrobial resistance in Canada. CMAJ 2002;167(8):885-91.
13. Casellas JM, Blanco MG, Pinto ME. The sleeping giant. Antimicrobial resistance. Infect Dis Clin North Am 1994;8:29-45.
14. World Health Organization. World Health Organization Report on Infectious Diseases 2000 [webpage]. Geneva, Switzerland: World Health Organization; 2000. Available from: http://www.who.int/infectious-disease-report/2000/index.html. Accessed 2004 Feb 10.
15. Canadian Committee on Antibiotic Resistance. National Policy Conference on Antibiotic Resistance, 5-7 October, 2002: summary of proceedings. Can Commun Dis Rep 2003;29:153-7.